UBS lowered the firm’s price target on Westlake (WLK) to $101 from $118 and keeps a Buy rating on the shares. While UBS still sees Westlake’s key commodity products, PVC and caustic, as more favorably positioned within the firm’s coverage due to a lower rate of capacity additions, the firm reduced its earnings forecast to reflect near-term challenges in the Performance and Essential Materials segment, the analyst tells investors in a research note. UBS sees Westlake’s earnings and valuation as near a trough.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WLK:
- Westlake price target lowered to $85 from $95 at Citi
- Westlake price target lowered to $90 from $105 at Deutsche Bank
- Westlake price target lowered to $94 from $103 at BMO Capital
- Hold Rating for Westlake Chemical Amid Weakened Short-Term Fundamentals and Challenging Commodity Backdrop
- Hold Rating for Westlake Chemical Amidst Operational Challenges and Tariff Uncertainties
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue